These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10613832)

  • 1. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
    Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
    Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome.
    Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
    Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gankyrin: a new oncoprotein and regulator of pRb and p53.
    Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
    Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin, the 26 S proteasome, the cell cycle and cancer.
    Mayer RJ; Fujita J
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.
    Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD
    Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
    Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
    Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity.
    Nagao T; Higashitsuji H; Nonoguchi K; Sakurai T; Dawson S; Mayer RJ; Itoh K; Fujita J
    J Biol Chem; 2003 Mar; 278(12):10668-74. PubMed ID: 12525503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation.
    Iwai A; Marusawa H; Kiuchi T; Higashitsuji H; Tanaka K; Fujita J; Chiba T
    J Gastroenterol; 2003; 38(8):751-8. PubMed ID: 14505129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
    Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
    World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
    Higashitsuji H; Liu Y; Mayer RJ; Fujita J
    Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma.
    Manjasetty BA; Quedenau C; Sievert V; Büssow K; Niesen F; Delbrück H; Heinemann U
    Proteins; 2004 Apr; 55(1):214-7. PubMed ID: 14997555
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.
    Silva FP; Hamamoto R; Furukawa Y; Nakamura Y
    Oncogene; 2006 Aug; 25(36):5063-70. PubMed ID: 16568080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
    Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
    Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.